Long-term prophylaxis in von Willebrand disease
Authors:
- Erik BerntorpEBErik Berntorp
- Pia PetriniPPPia Petrini
- 1 April 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 16 (Supplement) , S23-S26
Abstract
The majority of patients with von Willebrand disease (VWD) have a mild bleeding tendency that primarily involves mucosal bleeding. Some patients with the disorder, however, have severe episodes of mucosal or joint bleeding that can hamper daily activities and lead to significant joint impairment. Experience in the setting of severe hemophilia has shown the feasibility and benefits of prophylactic treatment to prevent bleeding and development of arthropathy. This approach also needs to be evaluated in patients with VWD who require repetitive treatment for bleeding episodes. Data from a series of 35 patients (with VWD types 3, 2A, 2B, and 1) who have received long-term prophylaxis at Malmö University Hospital and Karolinska University Hospital in Stockholm, Sweden, have demonstrated a substantial reduction of bleeding episodes since initiation of treatment. Patients who began prophylaxis at a young age (younger than 5 years) to prevent nose and mouth bleeds have had no joint bleeds and have no clinical signs of arthropathy. Treatment has been safe, with no cases of thrombosis, and no viral transmission among patients who received virus-attenuated von Willebrand factor-containing factor VIII concentrate. These data thus suggest that long-term prophylaxis is warranted in the majority of patients with type 3 VWD and in other subtypes with severe bleeding tendencies, and that such an approach may help in the avoidance of joint disease if started early. More clinical data and controlled trials are needed in order to formulate recommendations for prophylaxis in patients with VWD.Keywords
This publication has 8 references indexed in Scilit:
- Consensus perspectives on prophylactic therapy for haemophilia: summary statementHaemophilia, 2003
- Joint evaluation instruments for children and adults with haemophiliaHaemophilia, 2000
- Impact, Diagnosis and Treatment of von Willebrand DiseaseThrombosis and Haemostasis, 2000
- Primary prophylaxis in severe haemophilia should be started at an early age but can be individualizedBritish Journal of Haematology, 1999
- Haemophilia prophylaxis in young patients–a long‐term follow‐upJournal of Internal Medicine, 1997
- Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and BJournal of Internal Medicine, 1992
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Prophylaxis with Factor Concentrates in Preventing Hemophilic ArthropathyJournal of Pediatric Hematology/Oncology, 1991